Results from a new study of Japanese patients with type 2 diabetes showed once-weekly Trulicity ™ 0.75 mg provided greater hemoglobin A1c (A1C) reduction compared to once-daily Victoza ® 0.9 mg after ...
"These data not only reinforce once-weekly Trulicity as a safe and efficacious GLP-1 receptor agonist, but further support the value for Japanese patients, with greater A1C reductions compared to once ...
Zepbound and Trulicity are two U.S. Food and Drug Administration (FDA)-approved medications. When used alongside diet and ...
New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed that ...
INDIANAPOLIS, June 6, 2015 -- Results from a new study of Japanese patients with type 2 diabetes showed once-weekly Trulicity™ 0.75 mg provided greater hemoglobin A1c (A1C) reduction compared to ...
If you have diabetes, your health care provider may recommend Trulicity or Mounjaro, two medications approved by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results